• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[社区药房慢性肾脏病筛查。CRIERFAC研究:方法学描述]

[Screening for Chronic Kidney Disease in the Community Pharmacy. CRIERFAC Study: Description of the Methodology].

作者信息

Salar Ibáñez Luis, Espejo Guerrero José, Satué Eduardo, Pérez León Noemí, Martínez-Berganza Asensio M Lourdes

机构信息

Doctor en farmacia, Director de 'Farmacéuticos Comunitarios', Profesor asociado Universidad Cardenal Herrera - CEU, Farmacéutico comunitario en Valencia Universidad Cardenal Herrera España.

Doctor en Farmacia, Farmacéutico comunitario en Adra (Almería) España.

出版信息

Farm Comunitarios. 2024 Apr 11;16(2):5-13. doi: 10.33620/FC.2173-9218.(2024).12. eCollection 2024 Apr 15.

DOI:10.33620/FC.2173-9218.(2024).12
PMID:39156030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328524/
Abstract

ABSTRACT

Chronic kidney disease (CKD) is the existence of abnormalities in renal structure or function with an impact on health. This is usually considered when estimated glomerular filtration (eGF) falls under 60 mL/min/1.73m. Its clinical course leads to renal replacement therapy (dialysis or transplant) when eGF falls under 15 mL/min/1.73m. Screening in at risk populations has been proven to be cost-effective. The aim of this work is to perform CKD screening in the community pharmacy. In this publication we report and justify the methodology in detail.

METHODOLOGY

Pharmacists from the community pharmacies taking part selected patients who complied with inclusion and not exclusion criteria. Creatinine was measured by means of a finger prick and eGF calculated with the formula CKD-EPI. If this is lower than a set value, which depends on age, referral to the general practitioner takes place.

RESULTS

A total of 141 out of 200 pharmacies took part in the study. In all 2116 patients were recruited and 116 patients were lost. The final sample size was 2000 patients.

DISCUSSION

The protocol was successfully implemented by community pharmacists and was extremely well received by community pharmacy users. The age adjustment for eGF thresholds provides a novel additional filter. The aim is not to overburden primary care centres with potential referrals of false positives. Confirmation of the diagnosis is subject to voluntary communication by the patient to the pharmacist.

摘要

摘要

慢性肾脏病(CKD)是指存在影响健康的肾脏结构或功能异常。当估算肾小球滤过率(eGF)低于60 mL/(min·1.73m²)时,通常会考虑诊断为慢性肾脏病。当eGF低于15 mL/(min·1.73m²)时,其临床病程会导致肾脏替代治疗(透析或移植)。在高危人群中进行筛查已被证明具有成本效益。这项工作的目的是在社区药房开展慢性肾脏病筛查。在本出版物中,我们详细报告并论证了该方法。

方法

参与研究的社区药房的药剂师挑选符合纳入标准而非排除标准的患者。通过手指采血测量肌酐,并使用CKD-EPI公式计算eGF。如果该值低于取决于年龄的设定值,则将患者转诊至全科医生处。

结果

200家药房中有141家参与了该研究。总共招募了2116名患者,其中116名患者失访。最终样本量为2000名患者。

讨论

该方案由社区药剂师成功实施,并受到社区药房使用者的广泛好评。eGF阈值的年龄调整提供了一个新的附加筛选标准。目的是避免向初级保健中心转诊过多可能的假阳性病例。诊断的确认取决于患者是否自愿向药剂师告知情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320c/11328524/1533720c7805/FC16-02-02_gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320c/11328524/489f8f831aa8/FC16-02-02_gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320c/11328524/1533720c7805/FC16-02-02_gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320c/11328524/489f8f831aa8/FC16-02-02_gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/320c/11328524/1533720c7805/FC16-02-02_gf02.jpg

相似文献

1
[Screening for Chronic Kidney Disease in the Community Pharmacy. CRIERFAC Study: Description of the Methodology].[社区药房慢性肾脏病筛查。CRIERFAC研究:方法学描述]
Farm Comunitarios. 2024 Apr 11;16(2):5-13. doi: 10.33620/FC.2173-9218.(2024).12. eCollection 2024 Apr 15.
2
Evaluation of a chronic kidney disease risk assessment service in community pharmacies.社区药房慢性肾脏病风险评估服务的评估
Nephrology (Carlton). 2019 Mar;24(3):301-307. doi: 10.1111/nep.13247.
3
Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.社区药剂师主导的即时 eGFR 筛查:高危患者的慢性肾脏病早期检测。
Sci Rep. 2024 Mar 27;14(1):7284. doi: 10.1038/s41598-024-56765-0.
4
Community pharmacist intervention in patients with renal impairment.社区药剂师对肾功能损害患者的干预。
Int J Clin Pharm. 2015 Dec;37(6):1172-9. doi: 10.1007/s11096-015-0182-4. Epub 2015 Sep 18.
5
Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.基于社区药房的估算肾小球滤过率(eGFR)筛查,用于高危患者慢性肾脏病(CKD)的早期检测。
Can J Kidney Health Dis. 2020 May 18;7:2054358120922617. doi: 10.1177/2054358120922617. eCollection 2020.
6
Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.社区药房中慢性肾脏病患者的药学监护计划:检测肾毒性药物和剂量调整。可行性研究。
PLoS One. 2022 Dec 22;17(12):e0278648. doi: 10.1371/journal.pone.0278648. eCollection 2022.
7
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.在基层医疗环境中,由药剂师主导的针对慢性肾脏病高危人群或患者的筛查和干预的效果:一项群组随机试验方案。
BMJ Open. 2023 Dec 20;13(12):e079110. doi: 10.1136/bmjopen-2023-079110.
8
Comparison of the prevalence of kidney disease by proteinuria and decreased estimated glomerular filtration rate determined using three creatinine-based equations among patients admitted on medical wards of Masaka Regional Referral Hospital in Uganda: a prospective study.乌干达马萨卡地区转诊医院内科病房住院患者中,三种基于肌酐的方程评估的蛋白尿和估算肾小球滤过率降低与肾脏疾病患病率的比较:一项前瞻性研究。
BMC Nephrol. 2022 Jul 7;23(1):242. doi: 10.1186/s12882-022-02865-w.
9
Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.在社区人群中使用慢性肾脏病流行病学协作组(CKD-EPI)公式进行估算肾小球滤过率常规报告的影响:一项横断面队列研究。
Nephrology (Carlton). 2014 Sep;19(9):581-6. doi: 10.1111/nep.12283.
10
Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol.慢性肾脏病流行病学协作组(CKD-EPI)方程在估算糖尿病成年患者肾小球滤过率方面的诊断性能:一项系统评价和荟萃分析方案
BMJ Open. 2019 Aug 30;9(8):e031558. doi: 10.1136/bmjopen-2019-031558.

本文引用的文献

1
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.在基层医疗环境中,由药剂师主导的针对慢性肾脏病高危人群或患者的筛查和干预的效果:一项群组随机试验方案。
BMJ Open. 2023 Dec 20;13(12):e079110. doi: 10.1136/bmjopen-2023-079110.
2
Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.社区药房中慢性肾脏病患者的药学监护计划:检测肾毒性药物和剂量调整。可行性研究。
PLoS One. 2022 Dec 22;17(12):e0278648. doi: 10.1371/journal.pone.0278648. eCollection 2022.
3
Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients.
基于社区药房的估算肾小球滤过率(eGFR)筛查,用于高危患者慢性肾脏病(CKD)的早期检测。
Can J Kidney Health Dis. 2020 May 18;7:2054358120922617. doi: 10.1177/2054358120922617. eCollection 2020.
4
Prevalence of chronic kidney disease and associated factors in the Spanish population attended in primary care: Results of the IBERICAN study.西班牙初级保健就诊人群中慢性肾脏病的患病率及相关因素:伊比利亚研究结果
Med Clin (Barc). 2021 Feb 26;156(4):157-165. doi: 10.1016/j.medcli.2020.03.005. Epub 2020 May 12.
5
Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study.社区药剂师使用即时检验技术识别慢性肾脏病:一项试点研究。
Can Pharm J (Ott). 2020 Feb 13;153(2):84-87. doi: 10.1177/1715163520902495. eCollection 2020 Mar-Apr.
6
CKD: A Call for an Age-Adapted Definition.CKD:呼吁制定适合年龄的定义。
J Am Soc Nephrol. 2019 Oct;30(10):1785-1805. doi: 10.1681/ASN.2019030238. Epub 2019 Sep 10.
7
Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors.西班牙的慢性肾脏病:心血管危险因素累积的患病率及影响
Nefrologia (Engl Ed). 2018 Nov-Dec;38(6):606-615. doi: 10.1016/j.nefro.2018.04.004. Epub 2018 Jun 18.
8
Evaluation of a chronic kidney disease risk assessment service in community pharmacies.社区药房慢性肾脏病风险评估服务的评估
Nephrology (Carlton). 2019 Mar;24(3):301-307. doi: 10.1111/nep.13247.
9
Chronic Kidney Disease.慢性肾脏病。
Lancet. 2017 Mar 25;389(10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23.
10
[Community pharmacists' interventions to prevent and screen chronic kidney disease patients].[社区药剂师对慢性肾脏病患者的预防与筛查干预措施]
Nephrol Ther. 2017 Apr;13(2):87-92. doi: 10.1016/j.nephro.2016.06.006. Epub 2016 Oct 31.